• About
  • Archive
  • Privacy & Policy
  • Contact
Dana Blankenhorn
  • Home
  • About Dana
  • Posts
  • Contact Dana
  • Archive
  • A-clue.com
No Result
View All Result
  • Home
  • About Dana
  • Posts
  • Contact Dana
  • Archive
  • A-clue.com
No Result
View All Result
Dana Blankenhorn
No Result
View All Result
Home A-Clue

Sciencing is Hard

by Dana Blankenhorn
October 2, 2023
in A-Clue, education, innovation, intellectual property, investment, medical, Personal, Science, The 2020s and Beyond
0
0
SHARES
114
VIEWS
Share on FacebookShare on Twitter

My son became a working scientist a year ago. Since then, he has taught both of us an important lesson.

Sciencing is hard.

The process of doing science is not what is portrayed in the media. It’s frustrating. There are mistakes. There are missteps. There are scheduling conflicts, equipment breaks down, and theories don’t pan out.

This was reinforced by today’s announcement of the 2023 Nobel Prize in Medicine.

It went to Katalin Karikó, a Hungarian immigrant, and to Drew Weissman of the University of Pennsylvania, for their work on mRNA vaccines.

But it’s the back story that’s most important to me.


As Kariko explained in 2020, she was demoted in 1995 because, her colleagues insisted, mRNA could not be turned into therapies. It was only later, while copying papers, that she met Weissman. They tweaked her discovery by changing one component in the RNA to make it less immunogenic. They published this in 2005 and the rest is history.

There are many other stories like this. Most don’t result in Nobels. Some result in total failure. A research line that looks promising can become a dead end. My son saw it happen. Malcolm Gladwell talked about this in a 2020 podcast, set at the school where my son works.

The problem is that few places can have the patience Emory has, which lets dead ends as well as breakthroughs be proven over time. Most of the people doing the work don’t make the money professors make. Some are just students.

All are heroes.

Tags: COVID vaccinemRNANobel PrizeNobel Prize in Medicinesciencescience processsciencing
Previous Post

A Forgotten Moment

Next Post

Roll Over, Cloud Czars

Dana Blankenhorn

Dana Blankenhorn

Dana Blankenhorn began his career as a financial journalist in 1978, began covering technology in 1982, and the Internet in 1985. He started one of the first Internet daily newsletters, the Interactive Age Daily, in 1994. He recently retired from InvestorPlace and lives in Atlanta, GA, preparing for his next great adventure. He's a graduate of Rice University (1977) and Northwestern's Medill School of Journalism (MSJ 1978). He's a native of Massapequa, NY.

Next Post

Roll Over, Cloud Czars

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Post

AI is a Tool

AI is a Tool

May 22, 2025
The E-Transport Minority

Twilight of the Bike-y Bike

May 21, 2025
The Ultimate Scam

The Ultimate Scam

May 20, 2025
Game Changer

Game Changer

May 19, 2025
Subscribe to our mailing list to receives daily updates direct to your inbox!


Archives

Categories

Recent Comments

  • Dana Blankenhorn on The Death of Video
  • danablank on The Problem of the Moment (Is Not the Problem of the Moment)
  • cipit88 on The Problem of the Moment (Is Not the Problem of the Moment)
  • danablank on What I Learned on my European Vacation
  • danablank on Boomer Roomers

I'm Dana Blankenhorn. I have covered the Internet as a reporter since 1983. I've been a professional business reporter since 1978, and a writer all my life.

  • Italian Trulli

Browse by Category

Newsletter


Powered by FeedBlitz
  • About
  • Archive
  • Privacy & Policy
  • Contact

© 2023 Dana Blankenhorn - All Rights Reserved

No Result
View All Result
  • Home
  • About Dana
  • Posts
  • Contact Dana
  • Archive
  • A-clue.com

© 2023 Dana Blankenhorn - All Rights Reserved